Form 4: Lemaitre Vascular Director John A. Roush Acquires Shares Through Dividend Equivalent Rights
SEC Form 4 Filing
Director John A. Roush acquired shares of Lemaitre Vascular Inc. through the release of dividend equivalent rights associated with vesting restricted stock units and performance stock units.
Summary
- John A. Roush, a director at Lemaitre Vascular Inc., acquired a total of 12 shares of common stock.
- These shares were obtained through the release of dividend equivalent rights.
- The dividend equivalent rights were associated with the vesting of restricted stock unit awards granted on December 11, 2021, and December 12, 2022, as well as a performance stock unit award granted on December 12, 2022.
- The transactions occurred on December 11, 2024, and December 12, 2024.
- The price per share for these transactions was $0 as they were acquired through the release of dividend equivalent rights.
Sentiment
Score: 7
Explanation: The document reflects a routine transaction related to executive compensation. It is a positive sign that a director is increasing their stake in the company, but it is not a major event.
Positives
- The acquisition of shares by a director can be seen as a positive sign of confidence in the company's future.
Industry Context
This is a standard SEC Form 4 filing, which is common for company insiders when they acquire or dispose of company stock. It is a routine part of corporate governance and transparency.
Comparison to Industry Standards
- Form 4 filings are a standard practice for publicly traded companies in the United States.
- The acquisition of shares through dividend equivalent rights is a common method of compensation for executives and directors.
- The number of shares acquired is relatively small, suggesting this is a routine vesting event rather than a significant purchase.
Stakeholder Impact
- The acquisition of shares by a director may be viewed positively by shareholders as it indicates confidence in the company's future.
Key Dates
| Date | Description |
|---|---|
| 12/11/2021 | Date of grant for restricted stock unit award associated with some of the dividend equivalent rights. |
| 12/12/2022 | Date of grant for restricted stock unit and performance stock unit awards associated with some of the dividend equivalent rights. |
| 12/11/2024 | Date of acquisition of 6 shares through dividend equivalent rights. |
| 12/12/2024 | Date of acquisition of 6 shares through dividend equivalent rights. |
| 12/13/2024 | Date of filing of the Form 4. |
Keywords
Lemaitre Vascular, Director, John A. Roush, Dividend Equivalent Rights, Stock Acquisition, Restricted Stock Units, Performance Stock Units, Insider Trading, LMAT
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.